Aster DM Healthcare has received an order from the Hon’ble National Company Law Tribunal (NCLT), Hyderabad Bench, to convene meetings of shareholders and unsecured creditors for approval of its merger with Quality Care India Ltd (QCIL). The meetings are set to take place between February 27 and March 13, 2026. The merger has already secured approvals from the Competition Commission of India (CCI) and the stock exchanges.
Once completed, the merged entity, Aster DM Quality Care Ltd, will be among India’s top three hospital chains, with over 10,360 beds across the country. Aster Promoters and Blackstone will jointly promote the combined entity, which aims to expand access to high-quality medical care throughout India.
Dr. Azad Moopen, Founder & Chairman of Aster DM Healthcare, expressed confidence in the merger’s approval and the positive impact on the healthcare sector. He emphasized the integration strategy’s focus on leveraging complementary strengths, enhancing clinical excellence, and accelerating innovation. The combined entity will have a portfolio of four leading healthcare brands: Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare, with a goal to increase bed capacity to over 14,715 in the coming years.
The merger will also open doors for investments in advanced medical technologies and digital health platforms to improve patient care and outcomes across the country.
For more news and update, click here to download our mobile app – Veritas Daily
To explore advertising or sponsorship collaborations, click here to contact us
Leave a Reply